BMEAX
Price
$26.97
Change
+$0.01 (+0.04%)
Updated
Jul 13 closing price
Net Assets
2.13B
JEPAX
Price
$14.08
Change
-$0.01 (-0.07%)
Updated
Jul 13 closing price
Net Assets
5.06B
Interact to see
Advertisement

BMEAX vs JEPAX

BMEAX vs JEPAX Comparison Chart in %
View a ticker or compare two or three
VS
BMEAX vs. JEPAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEAX is a Buy and JEPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JEPAX has more cash in the bank: 5.07B vs. BMEAX (2.13B). JEPAX pays higher dividends than BMEAX: JEPAX (7.78) vs BMEAX (7.40). BMEAX was incepted earlier than JEPAX: BMEAX (28 years) vs JEPAX (8 years). BMEAX (1.22) is less costly to investors than JEPAX (0.84). JEPAX is a more actively managed with annual turnover of: 176.00 vs. BMEAX (130.00). BMEAX (5%) and JEPAX (5%) have equivalent initial investment costs. BMEAX (1000) and JEPAX (1000) have matching initial minimum investment requirements. BMEAX annual gain was more profitable for investors over the last year : 20.81 vs. JEPAX (7.93). BMEAX return over 5 years is better than : 57.24 vs. JEPAX (39.81).
BMEAXJEPAXBMEAX / JEPAX
Total Expense Ratio1.100.84131%
Annual Report Gross Expense Ratio1.220.84145%
Fund Existence28 years8 years-
Gain YTD11.3832.942387%
Front Load5%5%100%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.13B5.07B42%
Annual Yield % from dividends7.407.7895%
Returns for 1 year20.817.93262%
Returns for 3 years44.6528.42157%
Returns for 5 years57.2439.81144%
Returns for 10 years39.41N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLD234.145.72
+2.50%
Steel Dynamics
IPHA1.79N/A
+0.28%
Innate Pharma SA
PJT157.130.21
+0.13%
PJT Partners
INMD15.15-0.13
-0.85%
InMode Ltd
KPRX2.46-0.05
-1.99%
Kiora Pharmaceuticals Inc.